237690.KQ

ST Pharm Co.,Ltd. [237690.KQ] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

237690.KQ Stock Summary

In the News

237690.KQ Financial details

Company Rating
-
Market Cap
1440.24B
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
500
Dividend %
0.65%
Employees
566
Optionable
No
Shortable
Yes
Earnings
13 Nov 2023
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-3.13%
SMA50
7.77%
SMA100
-6.1%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
18.66M
Shs Float
0
-
-
-
-
Target Price
-
52W Range
69400.0-93500.0
52W High
-18.29%
52W Low
+10.09%
RSI
35
Rel Volume
0.36
Avg Volume
89.05K
Volume
32.23K
Perf Week
-7.28%
Perf Month
-4.74%
Perf Quarter
-2.68%
Perf Half Y
1.87%
-
-
-
-
Beta
0.90909
-
-
Volatility
2302.08%, 2033.14%
Prev Close
2.14%
Price
76400
Change
0.26%

237690.KQ Financial Performance

237690.KQ Dividend History

237690.KQ Frequently Asked Questions

What is ST Pharm Co.,Ltd. stock symbol ?

ST Pharm Co.,Ltd. is a KR stock and trading under the symbol 237690.KQ

What is ST Pharm Co.,Ltd. stock quote today ?

ST Pharm Co.,Ltd. stock price is $76400 today.

Is ST Pharm Co.,Ltd. stock public?

Yes, ST Pharm Co.,Ltd. is a publicly traded company.

Something similar

Top by Market Cap
BRH.DE
META
CORN
MSFT
GOOG
Interesting
HBI
MCI
PTLC
ALMDT.PA
TPX-B.TO
Same Price Range
196230.KS
181480.KS
005387.KS
004000.KS
028260.KS
Similar Market Cap
MLPL.JK
1288.HK
NTPC.NS
GRASIM.NS
001120.KS

Company Profile

  • Volume Average 89.05K
  • Market Capitalization 1440.24B
  • Employee 566
  • CEO Mr. Geun-Jo Im Ph.D.
  • Headquarters Seoul,KR
  • IPO Date 2016-06-23
  • Website http://www.stpharm.co.kr

ST Pharm Co. Ltd., a contract development manufacturing organization, provides products for pharmaceutical and non-pharmaceutical area in South Korea. The company offers chemistry manufacturing control (CMC) services, which includes analytical method development; in-house reference standard testing; analytical method qualification/validation; analytical characterization; and CMC documentation. It also provides oligonucleotide based products, such as antisense, siRNA, miRNA, aptamer, CpG, decoy, and other products; and monomer/phosphoramidite. In addition, the company offers generic APIs for anti-cancer, anti-coagulant, anti-fungal, anti-hyperlipidemia, anti-hypertensive, anti-tuberculosis, asthma, COPD, cough suppressant, diabetes mellitus, epilepsy, hepatitis B, and erectile dysfunction medicines, as well as MRI contrast agents. Further, it provides 2nd battery, electronic materials, and polymer catalysts. The company was formerly known as Samchully Pharmaceutical Company., Ltd. ST Pharm Co. Ltd. was founded in 1983 and is based in Seoul, South Korea.